cupric chloride has been researched along with alpha-synuclein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JH; Paik, SR; Shin, HJ | 1 |
| Anandhan, A; Bohovych, I; Franco, R; Griggs, AM; Khalimonchuk, O; Lee, J; Reyes-Reyes, EM; Rochet, JC; Rodriguez-Rocha, H; Seravalli, J; Stanciu, LA; Zavala-Flores, L | 1 |
2 other study(ies) available for cupric chloride and alpha-synuclein
| Article | Year |
|---|---|
Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
Topics: Alkylating Agents; alpha-Synuclein; Alzheimer Disease; Catalysis; Chlorides; Copper; Dicyclohexylcarbodiimide; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Ferric Compounds; Humans; Hydrogen Peroxide; Metals; Nerve Tissue Proteins; Oxidation-Reduction; Quinolines; Recombinant Proteins; Spectrometry, Fluorescence; Synucleins; Time Factors | 2000 |
Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.
Topics: alpha-Synuclein; Animals; Apoptosis; Caspases; Cells, Cultured; Copper; Cysteine Proteinase Inhibitors; Dopaminergic Neurons; Embryo, Mammalian; Gene Expression Regulation; Humans; Leupeptins; Mesencephalon; Mutation; Neuroblastoma; Proteolysis; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Tyrosine 3-Monooxygenase | 2015 |